Search Results - "Topp MD"

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts.

Authors: Caumanns, Joseph J. Li, Shang Meersma, Gert J. et al.

Source: Scientific Reports. 2/5/2025, Vol. 15 Issue 1, p1-15. 15p.

Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.

Authors: Oda, Yukari Niimi, Kaoru Yoshida, Kosuke et al.

Source: BMC Cancer. 11/13/2023, Vol. 23 Issue 1, p1-12. 12p.

Patient-derived xenografts: a relevant preclinical model for drug development.

Authors: Pompili, Luca Porru, Manuela Caruso, Carla et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 12/5/2016, Vol. 35, p1-8. 8p.

Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice.

Authors: Zeng, Mingtang Ruan, Zijing Tang, Jiaxi et al.

Source: Cancer Cell International. 6/21/2023, Vol. 23 Issue 1, p1-23. 23p.

Harnessing preclinical models for the interrogation of ovarian cancer.

Authors: Qin, Tianyu Fan, Junpeng Lu, Funian et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 9/16/2022, Vol. 41 Issue 1, p1-21. 21p.

Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer.

Authors: Mieulet, Virginie Garnier, Camille Kieffer, Yann et al.

Source: Scientific Reports. 2/18/2021, Vol. 11 Issue 1, p1-20. 20p.

The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis.

Authors: Xiao, Yangjiong Yu, Yang Jiang, Pengcheng et al.

Source: Cellular Oncology (2211-3428). Aug2020, Vol. 43 Issue 4, p669-680. 12p.

Applications of patient-derived tumor xenograft models and tumor organoids.

Authors: Yoshida, Go J.^1,2 (AUTHOR) go-yoshida@juntendo.ac.jp

Source: Journal of Hematology & Oncology. 1/7/2020, Vol. 13 Issue 1, p1-16. 16p.

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.

Authors: Nanni, Patrizia Landuzzi, Lorena Manara, Maria Cristina et al.

Source: Scientific Reports. 8/21/2019, Vol. 9 Issue 1, pN.PAG-N.PAG. 1p.

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.

Authors: Eun Jin Heo Young Jae Cho William Chi Cho et al.

Source: Cancer Research & Treatment. Oct2017, Vol. 49 Issue 4, p915-926. 12p.

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts.

Authors: Ricci, Francesca Guffanti, Federica Damia, Giovanna et al.

Source: Molecular Cancer. 5/30/2017, Vol. 16, p1-6. 6p. 2 Charts, 3 Graphs.

Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.

Authors: Tomar, Tushar de Jong, Steven Alkema, Nicolette G. et al.

Source: Genome Medicine. 10/20/2016, Vol. 8, p1-15. 15p.

Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma.

Authors: Ruifen Dong Wenan Qiang Haiyang Guo et al.

Source: Journal of Hematology & Oncology. 9/21/2016, Vol. 9, p1-11. 11p.

人源性卵巢癌异体移植模型的研究进展.

Alternate Title: Updates of Patient Derived Xenografts Model in Ovarian Tumors.

Authors: 吴建发 易晓芳

Source: Journal of International Obstetrics & Gynecology. Apr2016, Vol. 43 Issue 2, p140-144. 5p.

MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors.

Authors: Knorr, K L B Schneider, P A Meng, X W et al.

Source: Cell Death & Differentiation. Dec2015, Vol. 22 Issue 12, p2133-2142. 10p. 1 Diagram, 5 Graphs.

Preparation of poly(NIPAAm)-Pluronic F68 as a thermosensitive surfactant for a controlled drug release.

Authors: Sung-Wook Choi Hye Min Lee Tae-Joon Park et al.

Source: International Journal of Pharmaceutical Investigation. 2011, Vol. 1 Issue 2, p88-92. 5p.

High-throughput approaches for precision medicine in high-grade serous ovarian cancer.

Authors: Govindarajan, Meinusha Wohlmuth, Christoph Waas, Matthew et al.

Source: Journal of Hematology & Oncology. 10/9/2020, Vol. 13 Issue 1, pN.PAG-N.PAG. 1p.

Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy.

Authors: Tandaric L Bjørge L Lode MR et al.

Source: Molecular oncology [Mol Oncol] 2026 Mar 14. Date of Electronic Publication: 2026 Mar 14.

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer.

Authors: Hoppe MM Jaynes P Wardyn JD et al.

Source: EMBO molecular medicine [EMBO Mol Med] 2021 May 07; Vol. 13 (5), pp. e13366. Date of Electronic Publication: 2021 Mar 11.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

The roles of patient-derived xenograft models and artificial intelligence toward precision medicine.

Authors: Janitri V ArulJothi KN Ravi Mythili VM et al.

Source: MedComm [MedComm (2020)] 2024 Sep 25; Vol. 5 (10), pp. e745. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: China NLM ID: 101769925 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-2663 (Electronic) Linking ISSN: 26882663 NLM ISO Abbreviation: MedComm (2020) Subsets: PubMed not MEDLINE